The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders [1]

Linda M. Scott, Peter J. Campbell, E. Joanna Baxter, Tony Todd, Philip Stephens, Sarah Edkins, Wooster Richard, Michael R. Stratton, P. Andrew Futreal, Anthony R. Green

Research output: Contribution to journalLetterpeer-review

136 Scopus citations
Original languageEnglish (US)
Pages (from-to)2920-2921
Number of pages2
JournalBlood
Volume106
Issue number8
DOIs
StatePublished - Oct 2005

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this